ADJUVANT THERAPY OF NODE-NEGATIVE BREAST-CANCER

[1] STEROID-RECEPTORS, CELLULAR KINETICS, AND LYMPH-NODE STATUS AS PROGNOSTIC FACTORS IN BREAST-CANCER [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (01) : 59 - 66

[2] CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO

[3] 2-H

[4] CLARK GM, IN PRESS N ENGL J ME

[5] A RANDOMIZED CLINICAL-TRIAL EVALUATING SEQUENTIAL METHOTREXATE AND FLUOROURACIL IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR-NEGATIVE TUMORS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) : 473 - 478

[6] FISHER B, 1969, CANCER, V24, P1071, DOI 10.1002/1097-0142(196911)24:5<1071::AID-CNCR2820240533>3.0.CO

[7] 2-H

[8] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) : 479 - 484

[9] RELATIVE WORTH OF ESTROGEN OR PROGESTERONE-RECEPTOR AND PATHOLOGIC CHARACTERISTICS OF DIFFERENTIATION AS INDICATORS OF PROGNOSIS IN NODE NEGATIVE BREAST-CANCER PATIENTS - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL B-06 [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1076 - 1087

[10] ADJUVANT THERAPY OF NODE-NEGATIVE BREAST-CANCER - ANOTHER POINT OF VIEW - RESPONSE [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (13) : 1076 - 1076

[1] STEROID-RECEPTORS, CELLULAR KINETICS, AND LYMPH-NODE STATUS AS PROGNOSTIC FACTORS IN BREAST-CANCER [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (01) : 59 - 66

[2] CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO

[3] 2-H

[4] CLARK GM, IN PRESS N ENGL J ME

[5] A RANDOMIZED CLINICAL-TRIAL EVALUATING SEQUENTIAL METHOTREXATE AND FLUOROURACIL IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR-NEGATIVE TUMORS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) : 473 - 478

[6] FISHER B, 1969, CANCER, V24, P1071, DOI 10.1002/1097-0142(196911)24:5<1071::AID-CNCR2820240533>3.0.CO

[7] 2-H

[8] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) : 479 - 484

[9] RELATIVE WORTH OF ESTROGEN OR PROGESTERONE-RECEPTOR AND PATHOLOGIC CHARACTERISTICS OF DIFFERENTIATION AS INDICATORS OF PROGNOSIS IN NODE NEGATIVE BREAST-CANCER PATIENTS - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL B-06 [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1076 - 1087

[10] ADJUVANT THERAPY OF NODE-NEGATIVE BREAST-CANCER - ANOTHER POINT OF VIEW - RESPONSE [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (13) : 1076 - 1076